GSK, Teva Ask Justices To Take Lamictal Pay-For-Delay Case
GlaxoSmithKline and Teva have asked the U.S. Supreme Court to review the Third Circuit's decision that they could face antitrust claims over their settlement involving the anticonvulsant Lamictal, arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article